ID   LNCaP clone FGC
AC   CVCL_1379
SY   LNCaP-Clone-FGC; LNCaP.FGC; LNCaP-FGC; LNCaP FGC; LNCAPCLONEFGC; LNCaP-ATCC; LNCaP Fast Growing Colony
DR   BTO; BTO_0006095
DR   CLO; CLO_0007366
DR   CLO; CLO_0007367
DR   CLO; CLO_0051537
DR   EFO; EFO_0005726
DR   CLDB; cl3245
DR   CLDB; cl4960
DR   CLDB; cl5222
DR   4DN; 4DNSR4OQOB67
DR   Abcam; ab275470
DR   AddexBio; C0019003/4953
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1740
DR   BCRC; 60088
DR   BCRJ; 0149
DR   BioGRID_ORCS_Cell_line; 930
DR   BioSample; SAMN03471417
DR   BioSample; SAMN03472018
DR   BioSample; SAMN05292444
DR   BioSample; SAMN10988285
DR   cancercelllines; CVCL_1379
DR   CCRID; 3101HUMSCSP5021
DR   CCRID; 3101HUMTCHu173
DR   Cell_Model_Passport; SIDM00683
DR   ChEMBL-Cells; CHEMBL3308342
DR   ChEMBL-Targets; CHEMBL2366172
DR   CLS; 305220
DR   Cosmic; 688117
DR   Cosmic; 907788
DR   Cosmic-CLP; 907788
DR   DepMap; ACH-000977
DR   ECACC; 89110211
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS089RMT
DR   ENCODE; ENCBS184PDN
DR   ENCODE; ENCBS235TSM
DR   ENCODE; ENCBS260TRO
DR   ENCODE; ENCBS386ENC
DR   ENCODE; ENCBS387ENC
DR   ENCODE; ENCBS418ENC
DR   ENCODE; ENCBS421PUJ
DR   ENCODE; ENCBS422ENC
DR   ENCODE; ENCBS535BWO
DR   ENCODE; ENCBS668DEO
DR   ENCODE; ENCBS680JNS
DR   ENCODE; ENCBS687TQL
DR   ENCODE; ENCBS849SWQ
DR   ENCODE; ENCBS851ZZS
DR   ENCODE; ENCBS918PKZ
DR   GDSC; 907788
DR   GEO; GSM383954
DR   GEO; GSM383955
DR   GEO; GSM383956
DR   GEO; GSM651578
DR   GEO; GSM651579
DR   GEO; GSM827569
DR   GEO; GSM887271
DR   GEO; GSM888346
DR   GEO; GSM1633299
DR   GEO; GSM1633300
DR   GEO; GSM1633301
DR   GEO; GSM1633323
DR   GEO; GSM1633324
DR   GEO; GSM1633325
DR   GEO; GSM1670051
DR   GEO; GSM3407130
DR   GEO; GSM3407131
DR   GEO; GSM3407132
DR   GEO; GSM3407133
DR   GEO; GSM3407134
DR   GEO; GSM3407135
DR   IARC_TP53; 27698
DR   ICLC; HTL99011
DR   IZSLER; BS TCL 148
DR   KCB; KCB 200732YJ
DR   KCLB; 21740
DR   LiGeA; CCLE_749
DR   PharmacoDB; LNCaPCloneFGC_851_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1379
DR   PubChem_Cell_line; CVCL_1379
DR   RCB; RCB2144
DR   TKG; TKG 0603
DR   Ubigene; YC-C009
DR   Wikidata; Q54902825
RX   PubMed=2734981;
RX   PubMed=8104329;
RX   PubMed=10092147;
RX   PubMed=11172901;
RX   PubMed=12725112;
RX   PubMed=15389782;
RX   PubMed=15833837;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23117885;
RX   PubMed=23325432;
RX   PubMed=27397505;
RX   PubMed=28145883;
RX   PubMed=30305041;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/crl-1740-growth-and-morphology
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-rate-of-atcc-crl-1740
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544554
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 43 hours (PubMed=15389782); ~34 hours (ATCC=CRL-1740); ~36 hours (PBCF); 38.71 hours (JWGray panel).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (Cosmic-CLP=907788; DepMap=ACH-000977).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (Cosmic-CLP=907788; DepMap=ACH-000977).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (Cosmic-CLP=907788; DepMap=ACH-000977).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (DepMap=ACH-000977).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.89%; Native American=0.31%; East Asian, North=0%; East Asian, South=2.4%; South Asian=8.61%; European, North=28.39%; European, South=57.41% (PubMed=30894373).
CC   Misspelling: LNCaP.FCG; Note=Occasionally.
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): AddexBio=C0019003/4953; ATCC=CRL-1740; CCRID=3101HUMSCSP5021; CLS=305220; Cosmic-CLP=907788; ECACC=89110211; KCLB=21740; RCB=RCB2144; TKG=TKG 0603
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 11
ST   D18S51: 11,12
ST   D19S433: 13.2,15
ST   D21S11: 29,32.2
ST   D2S1338: 16
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9 (RCB=RCB2144)
ST   D7S820: 9,11 (ECACC=89110211; KCLB=21740)
ST   D7S820: 9.1,10.3 (AddexBio=C0019003/4953; ATCC=CRL-1740; CCRID=3101HUMSCSP5021; CLS=305220; TKG=TKG 0603)
ST   D7S820: 11 (Cosmic-CLP=907788)
ST   D8S1179: 12,14
ST   FGA: 19,20 (ATCC=CRL-1740)
ST   FGA: 19,20,21 (CLS=305220)
ST   Penta D: 12,12.4
ST   Penta E: 12,16
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17,18 (RCB=RCB2144)
ST   vWA: 16,18 (AddexBio=C0019003/4953; ATCC=CRL-1740; CCRID=3101HUMSCSP5021; CLS=305220; Cosmic-CLP=907788; ECACC=89110211; KCLB=21740; TKG=TKG 0603)
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0395 ! LNCaP
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
CH   CVCL_C0BI ! Abcam LNCaP clone FGC TMPRSS2 KO
CH   CVCL_U984 ! AILNCaP
CH   CVCL_C0Z9 ! JHU-LNCaP-SM
CH   CVCL_A1BN ! LNCaP AR-NTD/pHage
CH   CVCL_A1BM ! LNCaP AR-V7/pHage
CH   CVCL_A1BL ! LNCaP AR-V7/pLenti
CH   CVCL_E7J8 ! LNCaP clone FGC(Cas9)
CH   CVCL_C8W7 ! LNCaP Clone FGC-EGFP
CH   CVCL_A4BQ ! LNCaP clone FGC-Luc2
CH   CVCL_W668 ! LNCaP clone FGC.10
CH   CVCL_B413 ! LNCaP-17
CH   CVCL_WW88 ! LNCaP-19
CH   CVCL_B414 ! LNCaP-34
CH   CVCL_ZC87 ! LNCaP-95
CH   CVCL_ZX07 ! LNCAP-AAR
CH   CVCL_4791 ! LNCaP-AI
CH   CVCL_C7XA ! LNCaP-AR
CH   CVCL_F0L7 ! LNCaP-BicR
CH   CVCL_5J30 ! LNCaP-luc-M6
CH   CVCL_D3W5 ! LNCaP-r
CH   CVCL_WZ25 ! LNCaP-SL
CH   CVCL_E0XF ! Ubigene LNCAP Clone FGC BRCA2 KO
//
RX   PubMed=23117885; DOI=10.1158/0008-5472.CAN-12-3630; PMCID=PMC3549016;
RA   Li, Ying-Ming
RA   Chan, Siu-Chiu
RA   Brand, Lucas J.
RA   Hwang, Tae Hyun
RA   Silverstein, Kevin A.T.
RA   Dehm, Scott M.
RT   "Androgen receptor splice variants mediate enzalutamide resistance in
RT   castration-resistant prostate cancer cell lines.";
RL   Cancer Res. 73:483-489(2013).
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662;
RA   Rothenberg, S. Michael
RA   Mohapatra, Gayatry
RA   Rivera, Miguel N.
RA   Winokur, Daniel
RA   Greninger, Patricia
RA   Nitta, Mai
RA   Sadow, Peter M.
RA   Sooriyakumar, Gaya
RA   Brannigan, Brian W.
RA   Ulman, Matthew J.
RA   Perera, Rushika M.
RA   Wang, Rui
RA   Tam, Angela
RA   Ma, Xiao-Jun
RA   Erlander, Mark
RA   Sgroi, Dennis C.
RA   Rocco, James W.
RA   Lingen, Mark W.
RA   Cohen, Ezra E.W.
RA   Louis, David Neil
RA   Settleman, Jeffrey
RA   Haber, Daniel Arie
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//
RX   PubMed=28145883; DOI=10.18632/oncotarget.14850; PMCID=PMC5386661;
RA   Nouri, Mannan
RA   Caradec, Josselin
RA   Lubik, Amy Anne
RA   Li, Na
RA   Hollier, Brett G.
RA   Takhar, Mandeep
RA   Altimirano-Dimas, Manuel
RA   Chen, Meng-Qian
RA   Roshan-Moniri, Mani
RA   Butler, Miriam
RA   Lehman, Melanie
RA   Bishop, Jennifer L.
RA   Truong, Sarah
RA   Huang, Shih-Chieh
RA   Cochrane, Dawn R.
RA   Cox, Michael
RA   Collins, Catherine
RA   Gleave, Martin E.
RA   Erho, Nicholas
RA   Alshalafa, Mohamed
RA   Davicioni, Elai
RA   Nelson, Colleen C.
RA   Gregory-Evans, Cheryl Y.
RA   Karnes, R. Jeffrey
RA   Jenkins, Robert Brian
RA   Klein, Eric A.
RA   Buttyan, Ralph
RT   "Therapy-induced developmental reprogramming of prostate cancer cells
RT   and acquired therapy resistance.";
RL   Oncotarget 8:18949-18967(2017).
//
RX   PubMed=8104329; DOI=10.1002/pros.2990230206;
RA   Carroll, Alan G.
RA   Voeller, H. James
RA   Sugars, LaVencia
RA   Gelmann, Edward P.
RT   "p53 oncogene mutations in three human prostate cancer cell lines.";
RL   Prostate 23:123-134(1993).
//
RX   PubMed=30305041; DOI=10.1186/s12885-018-4848-x; PMCID=PMC6180441;
RA   Jividen, Kasey
RA   Kedzierska, Katarzyna Z.
RA   Yang, Chun-Song
RA   Szlachta, Karol
RA   Ratan, Aakrosh
RA   Paschal, Bryce M.
RT   "Genomic analysis of DNA repair genes and androgen signaling in
RT   prostate cancer.";
RL   BMC Cancer 18:960.1-960.20(2018).
//
RX   PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113;
RA   Bignell, Graham Robert
RA   Greenman, Christopher D.
RA   Davies, Helen R.
RA   Butler, Adam P.
RA   Edkins, Sarah
RA   Andrews, Jenny M.
RA   Buck, Gemma
RA   Chen, Lina
RA   Beare, David
RA   Latimer, Calli
RA   Widaa, Sara
RA   Hinton, Jonathan
RA   Fahey, Ciara
RA   Fu, Bei-Yuan
RA   Swamy, Sajani
RA   Dalgliesh, Gillian L.
RA   Teh, Bin Tean
RA   Deloukas, Panos
RA   Yang, Feng-Tang
RA   Campbell, Peter J.
RA   Futreal, P. Andrew
RA   Stratton, Michael Rudolf
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=15389782; DOI=10.1002/pros.20145;
RA   Gustavsson, Helene
RA   Welen, Karin
RA   Damber, Jan-Erik
RT   "Transition of an androgen-dependent human prostate cancer cell line
RT   into an androgen-independent subline is associated with increased
RT   angiogenesis.";
RL   Prostate 62:364-373(2005).
//
RX   PubMed=12725112; DOI=10.1385/1-59259-372-0:21;
RA   Russell, Pamela Joan
RA   Kingsley, Elizabeth A.
RT   "Human prostate cancer cell lines.";
RL   Methods Mol. Med. 81:21-39(2003).
//
RX   PubMed=23325432; DOI=10.1101/gr.147942.112; PMCID=PMC3589544;
RA   Varley, Katherine E.
RA   Gertz, Jason
RA   Bowling, Kevin M.
RA   Parker, Stephanie L.
RA   Reddy, Timothy E.
RA   Pauli-Behn, Florencia
RA   Cross, Marie K.
RA   Williams, Brian A.
RA   Stamatoyannopoulos, John A.
RA   Crawford, Gregory E.
RA   Absher, Devin Michael
RA   Wold, Barbara Jane
RA   Myers, Richard M.
RT   "Dynamic DNA methylation across diverse human cell lines and
RT   tissues.";
RL   Genome Res. 23:555-567(2013).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675;
RA   Dutil, Julie
RA   Chen, Zhi-Hua
RA   Monteiro, Alvaro N.A.
RA   Teer, Jamie K.
RA   Eschrich, Steven A.
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//
RX   PubMed=10092147; DOI=10.1007/s002400050082;
RA   Konig, Josee J.
RA   Teubel, Wilma J.
RA   van Steenbrugge, Gert Jan
RA   Romijn, Johannes C.
RA   Hagemeijer, Anne
RT   "Characterization of chromosome 8 aberrations in the prostate cancer
RT   cell line LNCaP-FGC and sublines.";
RL   Urol. Res. 27:3-8(1999).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103;
RA   Ghandi, Mahmoud
RA   Huang, Franklin W.
RA   Jane-Valbuena, Judit
RA   Kryukov, Gregory V.
RA   Lo, Christopher C.
RA   McDonald, E. Robert 3rd
RA   Barretina, Jordi Ginesta
RA   Gelfand, Ellen T.
RA   Bielski, Craig M.
RA   Li, Hao-Xin
RA   Hu, Kevin
RA   Andreev-Drakhlin, Alexander Y.
RA   Kim, Jaegil
RA   Hess, Julian M.
RA   Haas, Brian J.
RA   Aguet, Francois
RA   Weir, Barbara A.
RA   Rothberg, Michael V.
RA   Paolella, Brenton R.
RA   Lawrence, Michael Scott
RA   Akbani, Rehan
RA   Lu, Yi-Ling
RA   Tiv, Hong L.
RA   Gokhale, Prafulla C.
RA   de Weck, Antoine
RA   Mansour, Ali Amin
RA   Oh, Coyin
RA   Shih, Juliann
RA   Hadi, Kevin
RA   Rosen, Yanay
RA   Bistline, Jonathan
RA   Venkatesan, Kavitha
RA   Reddy, Anupama
RA   Sonkin, Dmitriy
RA   Liu, Manway
RA   Lehar, Joseph
RA   Korn, Joshua M.
RA   Porter, Dale A.
RA   Jones, Michael D.
RA   Golji, Javad
RA   Caponigro, Giordano
RA   Taylor, Jordan E.
RA   Dunning, Caitlin M.
RA   Creech, Amanda L.
RA   Warren, Allison C.
RA   McFarland, James M.
RA   Zamanighomi, Mahdi
RA   Kauffmann, Audrey
RA   Stransky, Nicolas
RA   Imielinski, Marcin
RA   Maruvka, Yosef E.
RA   Cherniack, Andrew D.
RA   Tsherniak, Aviad
RA   Vazquez, Francisca
RA   Jaffe, Jacob D.
RA   Lane, Andrew Alan
RA   Weinstock, David M.
RA   Johannessen, Cory M.
RA   Morrissey, Michael P.
RA   Stegmeier, Frank
RA   Schlegel, Robert
RA   Hahn, William Chun
RA   Getz, Gad
RA   Mills, Gordon B.
RA   Boehm, Jesse S.
RA   Golub, Todd Robert
RA   Garraway, Levi Alexander
RA   Sellers, William Raj
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//
RX   PubMed=11172901; DOI=10.1016/S0165-4608(00)00339-3;
RA   Strefford, Jonathan C.
RA   Lillington, Debra M.
RA   Young, Bryan Douglas
RA   Oliver, R. Timothy D.
RT   "The use of multicolor fluorescence technologies in the
RT   characterization of prostate carcinoma cell lines: a comparison of
RT   multiplex fluorescence in situ hybridization and spectral karyotyping
RT   data.";
RL   Cancer Genet. Cytogenet. 124:112-121(2001).
//
RX   PubMed=31978347; DOI=10.1016/j.cell.2019.12.023; PMCID=PMC7339254;
RA   Nusinow, David Paul
RA   Szpyt, John
RA   Ghandi, Mahmoud
RA   Rose, Christopher M.
RA   McDonald, E. Robert 3rd
RA   Kalocsay, Marian
RA   Jane-Valbuena, Judit
RA   Gelfand, Ellen T.
RA   Schweppe, Devin Karl
RA   Jedrychowski, Mark P.
RA   Golji, Javad
RA   Porter, Dale A.
RA   Rejtar, Tomas
RA   Wang, Y. Karen
RA   Kryukov, Gregory V.
RA   Stegmeier, Frank
RA   Erickson, Brian K.
RA   Garraway, Levi Alexander
RA   Sellers, William Raj
RA   Gygi, Steven P.
RT   "Quantitative proteomics of the Cancer Cell Line Encyclopedia.";
RL   Cell 180:387-402.e16(2020).
//
RX   PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775;
RA   Goncalves, Emanuel
RA   Poulos, Rebecca C.
RA   Cai, Zhao-Xiang
RA   Barthorpe, Syd
RA   Manda, Srikanth S.
RA   Lucas, Natasha
RA   Beck, Alexandra
RA   Bucio-Noble, Daniel
RA   Dausmann, Michael
RA   Hall, Caitlin
RA   Hecker, Michael
RA   Koh, Jennifer
RA   Lightfoot, Howard
RA   Mahboob, Sadia
RA   Mali, Iman
RA   Morris, James
RA   Richardson, Laura
RA   Seneviratne, Akila J.
RA   Shepherd, Rebecca
RA   Sykes, Erin
RA   Thomas, Frances
RA   Valentini, Sara
RA   Williams, Steven G.
RA   Wu, Yang-Xiu
RA   Xavier, Dylan
RA   MacKenzie, Karen L.
RA   Hains, Peter G.
RA   Tully, Brett
RA   Robinson, Phillip James
RA   Zhong, Qing
RA   Garnett, Mathew J.
RA   Reddel, Roger Robert
RT   "Pan-cancer proteomic map of 949 human cell lines.";
RL   Cancer Cell 40:835-849.e8(2022).
//
RX   PubMed=31395879; DOI=10.1038/s41467-019-11415-2; PMCID=PMC6687785;
RA   Yu, Katharine
RA   Chen, Bin
RA   Aran, Dvir
RA   Charalel, Joe
RA   Yau, Christina
RA   Wolf, Douglas M.
RA   van 't Veer, Laura J.
RA   Butte, Atul Janardhan
RA   Goldstein, Ted
RA   Sirota, Marina
RT   "Comprehensive transcriptomic analysis of cell lines as models of
RT   primary tumors across 22 tumor types.";
RL   Nat. Commun. 10:3574.1-3574.11(2019).
//
RX   PubMed=30971826; DOI=10.1038/s41586-019-1103-9;
RA   Behan, Fiona M.
RA   Iorio, Francesco
RA   Picco, Gabriele
RA   Goncalves, Emanuel
RA   Beaver, Charlotte M.
RA   Migliardi, Giorgia
RA   Santos, Rita
RA   Rao, Yanhua
RA   Sassi, Francesco
RA   Pinnelli, Marika
RA   Ansari, Rizwan
RA   Harper, Sarah
RA   Jackson, David Adam
RA   McRae, Rebecca
RA   Pooley, Rachel
RA   Wilkinson, Piers
RA   van der Meer, Dieudonne J.
RA   Dow, David
RA   Buser-Doepner, Carolyn A.
RA   Bertotti, Andrea
RA   Trusolino, Livio
RA   Stronach, Euan Alexander
RA   Saez-Rodriguez, Julio
RA   Yusa, Kosuke
RA   Garnett, Mathew J.
RT   "Prioritization of cancer therapeutic targets using CRISPR-Cas9
RT   screens.";
RL   Nature 568:511-516(2019).
//
RX   PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027;
RA   Barretina, Jordi Ginesta
RA   Caponigro, Giordano
RA   Stransky, Nicolas
RA   Venkatesan, Kavitha
RA   Margolin, Adam A.
RA   Kim, Sungjoon
RA   Wilson, Christopher J.
RA   Lehar, Joseph
RA   Kryukov, Gregory V.
RA   Sonkin, Dmitriy
RA   Reddy, Anupama
RA   Liu, Manway
RA   Murray, Lauren
RA   Berger, Michael F.
RA   Monahan, John E.
RA   Morais, Paula
RA   Meltzer, Jodi
RA   Korejwa, Adam
RA   Jane-Valbuena, Judit
RA   Mapa, Felipa A.
RA   Thibault, Joseph
RA   Bric-Furlong, Eva
RA   Raman, Pichai
RA   Shipway, Aaron
RA   Engels, Ingo H.
RA   Cheng, Jill
RA   Yu, Guo-Ying K.
RA   Yu, Jian-Jun
RA   Aspesi, Peter Jr.
RA   de Silva, Melanie
RA   Jagtap, Kalpana
RA   Jones, Michael D.
RA   Wang, Li
RA   Hatton, Charles
RA   Palescandolo, Emanuele
RA   Gupta, Supriya
RA   Mahan, Scott
RA   Sougnez, Carrie
RA   Onofrio, Robert C.
RA   Liefeld, Ted
RA   MacConaill, Laura Eleanor
RA   Winckler, Wendy
RA   Reich, Michael
RA   Li, Nan-Xin
RA   Mesirov, Jill P.
RA   Gabriel, Stacey B.
RA   Getz, Gad
RA   Ardlie, Kristin
RA   Chan, Vivien
RA   Myer, Vic E.
RA   Weber, Barbara L.
RA   Porter, Jeff
RA   Warmuth, Markus
RA   Finan, Peter
RA   Harris, Jennifer L.
RA   Meyerson, Matthew Langer
RA   Golub, Todd Robert
RA   Morrissey, Michael P.
RA   Sellers, William Raj
RA   Schlegel, Robert
RA   Garraway, Levi Alexander
RT   "The Cancer Cell Line Encyclopedia enables predictive modelling of
RT   anticancer drug sensitivity.";
RL   Nature 483:603-607(2012).
//
RX   PubMed=2734981; DOI=10.1007/BF00262025;
RA   Konig, Josee J.
RA   Kamst, Eric
RA   Hagemeijer, Anne
RA   Romijn, Johannes C.
RA   Horoszewicz, Julius Stanislaw
RA   Schroder, Fritz H.
RT   "Cytogenetic characterization of several androgen responsive and
RT   unresponsive sublines of the human prostatic carcinoma cell line
RT   LNCaP.";
RL   Urol. Res. 17:79-86(1989).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469;
RA   Iorio, Francesco
RA   Knijnenburg, Theo A.
RA   Vis, Daniel J.
RA   Bignell, Graham Robert
RA   Menden, Michael Patrick
RA   Schubert, Michael
RA   Aben, Nanne
RA   Goncalves, Emanuel
RA   Barthorpe, Syd
RA   Lightfoot, Howard
RA   Cokelaer, Thomas
RA   Greninger, Patricia
RA   van Dyk, Ewald
RA   Chang, Han
RA   de Silva, Heshani
RA   Heyn, Holger
RA   Deng, Xian-Ming
RA   Egan, Regina K.
RA   Liu, Qing-Song
RA   Mironenko, Tatiana
RA   Mitropoulos, Xeni
RA   Richardson, Laura
RA   Wang, Jin-Hua
RA   Zhang, Ting-Hu
RA   Moran, Sebastian
RA   Sayols, Sergi
RA   Soleimani, Maryam
RA   Tamborero, David
RA   Lopez-Bigas, Nuria
RA   Ross-Macdonald, Petra
RA   Esteller, Manel
RA   Gray, Nathanael S.
RA   Haber, Daniel Arie
RA   Stratton, Michael Rudolf
RA   Benes, Cyril Henri
RA   Wessels, Lodewyk F.A.
RA   Saez-Rodriguez, Julio
RA   McDermott, Ultan
RA   Garnett, Mathew J.
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=15833837; DOI=10.1158/0008-5472.CAN-04-3218;
RA   Lin, Biao-Yang
RA   White, James T.
RA   Lu, Wei
RA   Xie, Tao
RA   Utleg, Angelita Gaoiran
RA   Yan, Xiao-Wei
RA   Yi, Eugene C.
RA   Shannon, Paul
RA   Khrebtukova, Irina
RA   Lange, Paul Henry
RA   Goodlett, David Robinson
RA   Zhou, Dai-Xing
RA   Vasicek, Thomas Josepth
RA   Hood, Leroy Edward
RT   "Evidence for the presence of disease-perturbed networks in prostate
RT   cancer cells by genomic and proteomic analyses: a systems approach to
RT   disease.";
RL   Cancer Res. 65:3081-3091(2005).
//